Reaction

Disseminated Tuberculosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,513 reports · 71 co-occurring drugs

As of the last recalculation, Disseminated Tuberculosis appears in 2,513 FAERS reports alongside 71 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 171.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Pyrazinamide	181	171.9	175.3
Isoniazid	207	115.2	116.7
Rifampicin	86	72.9	73.5
Rifampin	112	66.5	67.0
Adalimumab-Fkjp	264	52.6	52.9
Adalimumab-Aaty	261	50.9	51.1
Adalimumab-Adaz	265	46.4	46.6
Infliximab	693	35.9	36.0
Basiliximab	50	35.9	36.1
Mycophenilic Acid	68	27.9	28.0
Moxifloxacin	41	24.5	24.6
Efavirenz	31	23.3	23.4
Valganciclovir Hydrochloride Powder,	30	20.6	20.7
Moxifloxacin Hydrochloride	48	20.0	20.0
Mycophenolic Acid	69	18.3	18.4
Azathioprine	175	17.6	17.6
Nevirapine	18	16.6	16.7
Prednisolone	318	16.6	16.6
Prednisolone Oral	318	16.6	16.6
Prednisolone Oral Solution	318	16.6	16.6
Anti-Thymocyte Globulin (Rabbit)	16	16.5	16.6
Tenofovir Disoproxil Fumarate Tablets	17	16.4	16.4
Lamivudine Oral	49	16.3	16.4
Valganciclovir	34	15.1	15.2
Valganciclovir Hydrochloride	34	15.1	15.2
Lamivudine	55	15.1	15.1
Tacrolimus Ointment 0.1%	203	14.6	14.6
Tacrolimus Extended-Release Capsules	203	14.6	14.6
Amikacin	29	14.2	14.3
Linezolid	49	13.9	13.9
Abacavir Sulfate	15	12.8	12.8
Mycophenolate Mofetil Hydrochloride	193	12.6	12.7
Mycophenolate Mofetil	192	12.6	12.6
Tacrolimus	217	12.5	12.5
Methotrexate	405	9.3	9.3
Busulfan	17	9.0	9.0
Fludarabine Phosphate	41	8.8	8.8
Methotrexate Sodium	430	8.6	8.6
Methylprednisolone	133	8.4	8.4
Alemtuzumab	19	8.2	8.2
Zidovudine	13	8.1	8.1
Daspone	9	7.7	7.7
Dapsone Gel, 5%	9	7.7	7.7
Mesalamine	50	7.5	7.5
Labetalol	12	7.5	7.5
Dapsone	9	7.0	7.0
Everolimus Tablets	14	6.9	7.0
Misoprostol	8	6.8	6.8
Piperacillin Sodium,Tazobactam Sodium	21	6.6	6.6
Anakinra	13	6.5	6.5
Piperacillin And Tazobactam	10	6.5	6.5
Adalimumab	455	6.3	6.3
Meropenem	22	5.7	5.7
Levofloxacin	41	5.7	5.7
Levofloxacin In 5% Dextrose	41	5.7	5.7
Piperacillin Sodium And Tazobactam Sodium	13	5.5	5.5
Azacitidine For	12	5.5	5.5
Sulfasalazine	50	5.4	5.4
Voriconazole Injection	14	5.4	5.4
Cefepime	9	5.2	5.2
Raltegravir	10	5.0	5.0
Ritonavir 100 Mg	9	5.0	5.0
Tenofovir Disoproxil Fumarate	19	4.8	4.8
Norepinephrine	6	4.7	4.7
Cefepime Hydrochloride	9	4.6	4.6
Golimumab	45	4.4	4.4
Certolizumab Pegol	60	4.3	4.3
Azacitidine	15	4.2	4.2
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	6	2.7	2.7
Ledipasvir And Sofosbuvir	4	1.7	1.7
Guselkumab	7	1.6	1.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.